Last reviewed · How we verify
Tadalafil 10 MG — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Tadalafil 10 MG (Tadalafil 10 MG) — Philip Kern.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tadalafil 10 MG TARGET | Tadalafil 10 MG | Philip Kern | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tadalafil 10 MG CI watch — RSS
- Tadalafil 10 MG CI watch — Atom
- Tadalafil 10 MG CI watch — JSON
- Tadalafil 10 MG alone — RSS
Cite this brief
Drug Landscape (2026). Tadalafil 10 MG — Competitive Intelligence Brief. https://druglandscape.com/ci/tadalafil-10-mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab